# Direct Thrombin Inhibitors

Direct thrombin inhibitors prevent cleavage of fibrinogen to fibrin, and are therefore very effective anticoagulants.

|Property|Dabigatran
|--|--|
|**Class**|NOAC
|**Uses**|VTE prophylaxis, AF
|**Presentation**|75/110mg Capsules
|**Route of Administration**|PO
|**Dosing**|VTE: 220mg daily, AF: 150mg BD
|**Absorption**|6.5% bioavailability
|**Distribution**|35% protein bound
|**Metabolism**|Prodrug - activated by plasma and hepatic esterases
|**Elimination**|Renal elimination of active drug
|**Haeme**|Haemorrhage
|**Immune**|Allergy
|**Other**|Significant interactions with amiodarone, quinidine, St. John's Wort, as well as other anticoagulant and antiplatelet agents. Irreversible, though it is dialysable.

---
##References
Smith Scarth Sasada
Peck and Hill